Immunogenicity

Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults

Influenza Vaccination Strategy for Patients With Hematologic Malignancy

Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With Leishmaniasis

Immunogenicity of COVID-19 Vaccine on Heterologous Schedule

Real-world Immunogenicity of Anti-IL5/5a Antibody

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia

Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular Edema

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30

Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia

COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS

Pregnant and Lactating Individuals & Newborns COVID-19 Vaccination Prospective Cohort Study

Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults

A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2

New Generation mRNA Booster Vaccine Against Emerging VOCs

mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

Protectivity and Safety Following Recombinant Hepatitis B Vaccine

EMaBS TB Vaccine Study

Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B